Japan Specialist

Mark Chadwick

Over 20 years experience in equities and asset management in Asia and Japan. Qualified CFA with experience analyzing companies as a buy-side analyst. In-depth knowledge of company fundamental analysis, corporate governance and valuations.

Ricoh (7752):  Activists Were Early, the Consensus Is Late

Equity Bottom-Up

<ul>
<li>Ricoh: Patient activist Effissimo is backing Ricoh’s shift from printers to digital services, betting operational discipline can lift returns from a structurally declining hardware base.</li>
<li>KH Neochem: Strategic Capital’s growing stake in KH Neochem targets sharper capital allocation and governance, as cyclical weakness masks valuable semiconductor-linked specialty chemical franchises.</li>
<li>OPTEX: GMO’s quiet engagement at OPTEX spotlights surplus cash and discounted valuation, raising the prospect of improved shareholder returns at the sensing-technology mid-cap.</li>
</ul>


Ricoh: Patient activist Effissimo is backing Ricoh’s shift from printers to digital services, betting operational discipline can lift returns from a structurally declining hardware base.
KH Neochem: Strategic Capital’s growing stake in KH Neochem targets sharper capital allocation and governance, as cyclical weakness masks valuable semiconductor-linked specialty chemical franchises.
OPTEX: GMO’s quiet engagement at OPTEX spotlights surplus cash and discounted valuation, raising the prospect of improved shareholder returns at the sensing-technology mid-cap.


Japan Activism Briefs | OPTEX, KH Neochem, Ricoh

Ricoh Company Ltd

Japan Activism Briefs | OPTEX, KH Neochem, Ricoh